Development of a method for expression and purification of the regulatory C2-like domain of human 5-lipoxygenase

Protein Expression and Purification

Volumn 59, Issue 1, 2008, Pages 110-116

  Michel, Angela A Y ^a   Steinhilber, Dieter ^a   Werz, Oliver ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

5 Lipoxygenase; C2 domain; Leukotriene

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; HYBRID PROTEIN; PROTEINASE; TEV PROTEASE; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ARACHIDONATE 5-LIPOXYGENASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOPEPTIDASES; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS;

ESCHERICHIA COLI; NICOTIANA TABACUM; TOBACCO ETCH VIRUS;

EID: 40849119794     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.01.010     Document Type: Article

References (26)

1. Werz O. 5-Lipoxygenase: cellular biology and molecular pharmacology. Curr. Drug Targets Inflamm. Allergy 1 (2002) 23-44
2. Werz O. 5-Lipoxygenase: regulation and pharmacology. Med. Chem. Rev. 1 (2004) 201-223
3. Rådmark O. Arachidonate 5-lipoxygenase. Prostaglandins Other Lipid Mediat. 68-69 (2002) 211-234
4. Percival M.D. Human 5-lipoxygenase contains an essential iron. J. Biol. Chem. 266 (1991) 10058-10061
5. Chasteen N.D., Grady J.K., Skorey K.I., Neden K.J., Riendeau D., and Percival M.D. Characterization of the non-heme iron center of human 5-lipoxygenase by electron paramagnetic resonance, fluorescence, and ultraviolet-visible spectroscopy: redox cycling between ferrous and ferric states. Biochemistry 32 (1993) 9763-9771
6. Hörnig C., Albert D., Fischer L., Hörnig M., Rådmark O., Steinhilber D., and Werz O. 1-Oleoyl-2-acetylglycerol stimulates 5-lipoxygenase activity via a putative (phospho) lipid binding site within the N-terminal C2-like domain. J. Biol. Chem. 280 (2005) 26913-26921
7. Peters-Golden M., and Brock T.G. 5-Lipoxygenase and FLAP. Prostaglandins Leukot. Essent. Fatty Acids 69 (2003) 99-109
8. Pouliot M., McDonald P.P., Krump E., Mancini J.A., McColl S.R., Weech P.K., and Borgeat P. Co-localization of cytosolic phospholipase A2, 5-lipoxygenase, and 5-lipoxygenase-activating protein at the nuclear membrane of A23187-stimulated human neutrophils. Eur. J. Biochem. 238 (1996) 250-258
9. Dixon R.A., Diehl R.E., Opas E., Rands E., Vickers P.J., Evans J.F., Gillard J.W., and Miller D.K. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343 (1990) 282-284
10. Werz O., Bürkert E., Fischer L., Szellas D., Dishart D., Samuelsson B., Rådmark O., and Steinhilber D. Extracellular signal-regulated kinases phosphorylate 5-lipoxygenase and stimulate 5-lipoxygenase product formation in leukocytes. FASEB J. 16 (2002) 1441-1443
11. Werz O., Klemm J., Samuelsson B., and Rådmark O. 5-Lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases. Proc. Natl. Acad. Sci. USA 97 (2000) 5261-5266
12. Luo M., Jones S.M., Phare S.M., Coffey M.J., Peters-Golden M., and Brock T.G. Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523. J. Biol. Chem. 279 (2004) 41512-41520
13. Hammarberg T., Provost P., Persson B., and Rådmark O. The N-terminal domain of 5-lipoxygenase binds calcium and mediates calcium stimulation of enzyme activity. J. Biol. Chem. 275 (2000) 38787-38793
14. Rådmark O., Werz O., Steinhilber D., and Samuelsson B. 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. 32 (2007) 332-341
15. Werz O., and Steinhilber D. Development of 5-lipoxygenase inhibitors-lessons from cellular enzyme regulation. Biochem. Pharmacol. 70 (2005) 327-333
16. Allard J.B., and Brock T.G. Structural organization of the regulatory domain of human 5-lipoxygenase. Curr. Protein Pept. Sci. 6 (2005) 125-131
17. Nalefski E.A., and Falke J.J. The C2 domain calcium-binding motif: structural and functional diversity. Protein Sci. 5 (1996) 2375-2390
18. 2+-binding domain. J. Biol. Chem. 273 (1998) 15879-15882
19. Kulkarni S., Das S., Funk C.D., Murray D., and Cho W. Molecular basis of the specific subcellular localization of the C2-like domain of 5-lipoxygenase. J. Biol. Chem. 277 (2002) 13167-13174
20. Chen X.S., and Funk C.D. The N-terminal "beta-barrel" domain of 5-lipoxygenase is essential for nuclear membrane translocation. J. Biol. Chem. 276 (2001) 811-818
21. Rakonjac M., Fischer L., Provost P., Werz O., Steinhilber D., Samuelsson B., and Rådmark O. Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production. Proc. Natl. Acad. Sci. USA 103 (2006) 13150-13155
22. 2+-dependent resistance of 5-lipoxygenase activity against inhibition by glutathione peroxidase-1. J. Biol. Chem. 278 (2003) 42846-42853
23. Chen X.S., Zhang Y.Y., and Funk C.D. Determinants of 5-lipoxygenase nuclear localization using green fluorescent protein/5-lipoxygenase fusion proteins. J. Biol. Chem. 273 (1998) 31237-31244
24. Werz O., Szellas D., Henseler M., and Steinhilber D. Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity. Mol. Pharmacol. 54 (1998) 445-451
25. Denis D., Falgueyret J.P., Riendeau D., and Abramovitz M. Characterization of the activity of purified recombinant human 5-lipoxygenase in the absence and presence of leukocyte factors. J. Biol. Chem. 266 (1991) 5072-5079
26. Zhang Y.Y., Hammarberg T., Rådmark O., Samuelsson B., Ng C.F., Funk C.D., and Loscalzo J. Analysis of a nucleotide-binding site of 5-lipoxygenase by affinity labelling: binding characteristics and amino acid sequences. Biochem. J. 351 Pt 3 (2000) 697-707